ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket20095424-27ketendo-4444Research ArticleСтатьиArticlesНовости мировой тиреоидологииNovosti mirovoy tireoidologiiSviridonovaM A-20091512200954ТОМ 5, №4 (2009)2427Copyright © Sviridonova M.A., 20092009Sviridonova M.A.Sviridonova M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/4444

1. Потребление алкоголя и рак щитовидной железы 2. Фолликулярная неоплазия 3. Лечение зоба у плода 4. Остаточная тиреоидная ткань 5. Референсный интервал для уровня ТТГ 6. Выбор активности радиоактивного йода 7. Риск развития болезни Грейвса в семьях пациентов 8. Стоимость лечения болезни Грейвса 9. Аутоиммунный тиреоидит и пубертат 10. Эндокринная офтальмопатия и терапия радиоактивным йодом 11. Сцинтиграфия щитовидной железы во время беременности 12. Ранняя йодная профилактика во время беременности

ReferencesMeinhold C.L., Park Y., Stolzenberg-Solomon R.Z. et al. Alcohol intake and risk of thyroid cancer in the NIHAARP Diet and Health Study Br. J. Cancer. 2009. V. 101. P. 1630–1634.Meinhold C.L., Park Y., Stolzenberg-Solomon R.Z. et al. Alcohol intake and risk of thyroid cancer in the NIHAARP Diet and Health Study Br. J. Cancer. 2009. V. 101. P. 1630–1634.Marhefka G.D., McDivitt J.D., Shakir K.M., Drake A.J. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol. 2009. V. 53. P. 517–523.Marhefka G.D., McDivitt J.D., Shakir K.M., Drake A.J. Diagnosis of follicular neoplasm in thyroid nodules by fine needle aspiration cytology: does the result, benign vs. suspicious for a malignant process, in these nodules make a difference? Acta Cytol. 2009. V. 53. P. 517–523.Ribault V., Castanet M., Bertrand A.M. et al. Experience with intraamniotic thyroxine treatment in nonimmune fetal goitrous hypothyroidism in 12 cases J. Clin. Endocrinol. Metab. 2009. V. 94. P. 3731–3739.Ribault V., Castanet M., Bertrand A.M. et al. Experience with intraamniotic thyroxine treatment in nonimmune fetal goitrous hypothyroidism in 12 cases J. Clin. Endocrinol. Metab. 2009. V. 94. P. 3731–3739.D’Andrea V., Cantisani V., Catania A. et al. Thyroid tissue remnants after “total thyroidectomy” G. Chir. 2009. V. 30. P. 339–344.D’Andrea V., Cantisani V., Catania A. et al. Thyroid tissue remnants after “total thyroidectomy” G. Chir. 2009. V. 30. P. 339–344.Ross H.A., den Heijer M., Hermus A.R., Sweep F.C. Composite reference interval for thyroid-stimulating hormone and free thyroxine, comparison with common cutoff values, and reconsideration of subclinical thyroid disease Clin. Chem. 2009. V. 55. P. 2019–2025.Ross H.A., den Heijer M., Hermus A.R., Sweep F.C. Composite reference interval for thyroid-stimulating hormone and free thyroxine, comparison with common cutoff values, and reconsideration of subclinical thyroid disease Clin. Chem. 2009. V. 55. P. 2019–2025.de Rooij A., Vandenbroucke J.P., Smit J.W. et al. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis Eur. J. Endocrinol. 2009. V. 161(5). P. 771–777; epub. 2009, Aug. 11.de Rooij A., Vandenbroucke J.P., Smit J.W. et al. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis Eur. J. Endocrinol. 2009. V. 161(5). P. 771–777; epub. 2009, Aug. 11.Hemminki K., Shu X., Li X. et al. Familial risks for hospitalized Graves’ disease and goiter Eur. J. Endocrinol. 2009. V. 161. P. 623–629.Hemminki K., Shu X., Li X. et al. Familial risks for hospitalized Graves’ disease and goiter Eur. J. Endocrinol. 2009. V. 161. P. 623–629.In H., Pearce E.N., Wong A.K., Burgess J.F. et al. Treatment options for Graves disease: a cost-effectiveness analysis J. Am. Coll. Surg. 2009. V. 209. P. 170–179.In H., Pearce E.N., Wong A.K., Burgess J.F. et al. Treatment options for Graves disease: a cost-effectiveness analysis J. Am. Coll. Surg. 2009. V. 209. P. 170–179.Mariotti S., Prinzis A., Ghiani M. et al. Puberty is associated with a marked increase of the female sex predominance in chronic autoimmune thyroiditis Horm. Res. 2009. V. 72. P. 52–56.Mariotti S., Prinzis A., Ghiani M. et al. Puberty is associated with a marked increase of the female sex predominance in chronic autoimmune thyroiditis Horm. Res. 2009. V. 72. P. 52–56.Vannucchi G., Campi I., Covelli D. et al. Graves’ orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis J. Clin. Endocrinol. Metab. 2009. V. 94. P. 3381–3386.Vannucchi G., Campi I., Covelli D. et al. Graves’ orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis J. Clin. Endocrinol. Metab. 2009. V. 94. P. 3381–3386.Schaefer C., Meister R., Wentzeck R., Weber-Schoendorfer C. Fetal outcome after technetium scintigraphy in early pregnancy Reprod. Toxicol. 2009. V. 28. P. 161–166.Schaefer C., Meister R., Wentzeck R., Weber-Schoendorfer C. Fetal outcome after technetium scintigraphy in early pregnancy Reprod. Toxicol. 2009. V. 28. P. 161–166.Berbel P., Mestre J.L., Santamarнa A. et al. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation Thyroid. 2009. V. 19. P. 511–519.Berbel P., Mestre J.L., Santamarнa A. et al. Delayed neurobehavioral development in children born to pregnant women with mild hypothyroxinemia during the first month of gestation: the importance of early iodine supplementation Thyroid. 2009. V. 19. P. 511–519.

The authors declare that there are no conflicts of interest present.